SMS Lifesciences India Limited (BOM:540679)
India
· Delayed Price · Currency is INR 1,323.60
-10.15 (-0.76%)
At close: Apr 30, 2025
SMS Lifesciences India Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2016 - 2019 |
| Revenue | 3,456 | 3,060 | 3,156 | 3,501 | 2,656 | 2,608 | Upgrade
|
| Revenue Growth (YoY) | 23.56% | -3.04% | -9.86% | 31.81% | 1.85% | -30.98% | Upgrade
|
| Cost of Revenue | 2,243 | 2,097 | 2,289 | 2,605 | 1,878 | 1,986 | Upgrade
|
| Gross Profit | 1,213 | 962.44 | 866.62 | 895.96 | 778.39 | 621.63 | Upgrade
|
| Selling, General & Admin | 540.51 | 497.5 | 440.44 | 400.72 | 307.96 | 267.1 | Upgrade
|
| Other Operating Expenses | 181.38 | 152.73 | 137.82 | 148.64 | 167.97 | 100.12 | Upgrade
|
| Operating Expenses | 871.7 | 799.6 | 686.15 | 649.42 | 554.54 | 445.84 | Upgrade
|
| Operating Income | 341.04 | 162.84 | 180.47 | 246.54 | 223.85 | 175.78 | Upgrade
|
| Interest Expense | -93.12 | -99.53 | -64.24 | -57 | -41.56 | -45.5 | Upgrade
|
| Interest & Investment Income | 2.76 | 2.76 | 3.95 | 3.25 | 4.28 | 2.91 | Upgrade
|
| Currency Exchange Gain (Loss) | 18.22 | 18.22 | 3.1 | 9.38 | 9.28 | 12.69 | Upgrade
|
| Other Non Operating Income (Expenses) | 24.73 | 14.19 | 19.14 | -2.65 | -0.27 | 0.4 | Upgrade
|
| EBT Excluding Unusual Items | 293.64 | 98.48 | 142.43 | 199.52 | 195.57 | 146.27 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -0.01 | 0.87 | 0.11 | 0.41 | Upgrade
|
| Other Unusual Items | - | - | 23.52 | 126.92 | - | - | Upgrade
|
| Pretax Income | 293.63 | 98.47 | 165.93 | 327.31 | 195.68 | 146.68 | Upgrade
|
| Income Tax Expense | 76.39 | 35.19 | 52.16 | 74.31 | 60.11 | 44.85 | Upgrade
|
| Earnings From Continuing Operations | 217.25 | 63.28 | 113.77 | 253 | 135.57 | 101.83 | Upgrade
|
| Minority Interest in Earnings | 13.16 | 27.65 | 0.85 | 0.22 | - | - | Upgrade
|
| Net Income | 230.4 | 90.93 | 114.63 | 253.22 | 135.57 | 101.83 | Upgrade
|
| Net Income to Common | 230.4 | 90.93 | 114.63 | 253.22 | 135.57 | 101.83 | Upgrade
|
| Net Income Growth | 370.85% | -20.68% | -54.73% | 86.79% | 33.13% | -42.94% | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| EPS (Basic) | 76.19 | 30.08 | 37.92 | 83.76 | 44.84 | 33.68 | Upgrade
|
| EPS (Diluted) | 76.19 | 30.08 | 37.92 | 83.76 | 44.84 | 33.68 | Upgrade
|
| EPS Growth | 370.69% | -20.68% | -54.73% | 86.79% | 33.13% | -42.94% | Upgrade
|
| Free Cash Flow | - | 34.38 | -338.56 | -623.94 | -3.87 | -88.07 | Upgrade
|
| Free Cash Flow Per Share | - | 11.37 | -111.98 | -206.38 | -1.28 | -29.13 | Upgrade
|
| Dividend Per Share | - | 1.500 | 1.500 | 1.500 | 1.500 | - | Upgrade
|
| Gross Margin | 35.09% | 31.46% | 27.46% | 25.59% | 29.31% | 23.84% | Upgrade
|
| Operating Margin | 9.87% | 5.32% | 5.72% | 7.04% | 8.43% | 6.74% | Upgrade
|
| Profit Margin | 6.67% | 2.97% | 3.63% | 7.23% | 5.10% | 3.91% | Upgrade
|
| Free Cash Flow Margin | - | 1.12% | -10.73% | -17.82% | -0.15% | -3.38% | Upgrade
|
| EBITDA | 514.25 | 305.31 | 281.96 | 341.75 | 297.38 | 249.33 | Upgrade
|
| EBITDA Margin | 14.88% | 9.98% | 8.94% | 9.76% | 11.20% | 9.56% | Upgrade
|
| D&A For EBITDA | 173.21 | 142.47 | 101.49 | 95.21 | 73.53 | 73.55 | Upgrade
|
| EBIT | 341.04 | 162.84 | 180.47 | 246.54 | 223.85 | 175.78 | Upgrade
|
| EBIT Margin | 9.87% | 5.32% | 5.72% | 7.04% | 8.43% | 6.74% | Upgrade
|
| Effective Tax Rate | 26.02% | 35.74% | 31.43% | 22.70% | 30.72% | 30.58% | Upgrade
|
| Revenue as Reported | 3,505 | 3,098 | 3,186 | 3,518 | 2,674 | 2,631 | Upgrade
|
| Advertising Expenses | - | 3.71 | 5.19 | 0.9 | 1.04 | 1.22 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.